Review articlePublished 29 Jul 2024
Smart Nanocarriers for Controlled Release of Therapeutics in Inflammatory Diseases
Department of Clinical and Biological Sciences, University of Torino, Japan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Inflammatory diseases pose significant challenges in treatment due to their chronic nature and complex pathophysiology. Smart nanocarriers have emerged as promising platforms for delivering therapeutics with precision and efficacy. This article reviews the design principles, mechanisms, and recent advancements in smart nanocarriers for controlled release of therapeutics in inflammatory diseases. Key strategies for targeting inflamed tissues, modulating immune responses, and enhancing therapeutic outcomes are discussed, highlighting the transformative potential of nanotechnology in personalized medicine.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Pharmaceutics & Organic Process Research
- SubjectPharmaceutical Sciences
- SubjectChemistry
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Toshimori Beall”